Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines
- 1 March 1989
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 25 (2) , 114-116
- https://doi.org/10.1007/bf00692350
Abstract
Summary In 1986 we reported on the capacity ofcis-diamminedichloroplatinum(II) (cisplatin, CDDP) to induce erythroid cellular differentiation in the K562 cell [9]. To continue our study of the differentiating activity of cisplatin, we treated two human neuroblastoma cell lines with different doses of the drug in vitro. Both cell lines showed changes in morphology; however, only one achieved a fully differentiated neuronal phenotype (cisplatin concentration 1 μg/ml). The differentiated neuroblastoma cells exhibited extensive neurite outgrowth that reached maximal elongation after 5 days of culture, forming several interconnections. Cisplatin could induce neuronal differentiation, as did retinoic acid, a neuroblastoma-differentiating agent. The results show that cisplatin should be a candidate for further in vitro and in vivo studies of induced differentiation.Keywords
This publication has 8 references indexed in Scilit:
- COORDINATE CHANGES IN NEURONAL PHENOTYPE AND SURFACE-ANTIGEN EXPRESSION IN HUMAN NEUROBLASTOMA CELL VARIANTS1987
- Resistant and relapsing neuroblastoma: Improved response rate with a new multiagent regimen (OC‐HDP) including high‐dose cisplatinumMedical and Pediatric Oncology, 1987
- Cisplatin induces modulation of transferrin receptor during cellular differentiation in vitroCancer Chemotherapy and Pharmacology, 1986
- Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell linesExperimental Cell Research, 1983
- Biochemical and Morphological Study of Adriamycin-Induced Changes in Murine Neuroblastoma CellsOncology, 1982
- INDUCERS OF ERYTHROID-DIFFERENTIATION IN K562 HUMAN-LEUKEMIA CELLS1981